Health-Related Quality of Life Impact of EUFLEXXA in a Randomized Clinical Trial
Pharmaceutica Analytica Acta (5(8):1-5)
Data from the FLEXX Trial and FLEXX Trial extension study were used in order to evaluate the effect of bioengineered hyaluronic acid (BioHA) on quality of life. Short-Form 36 (SF-36) data from the FLEXX trial was compared to United States SF-36 normative values, as well as normative values for persons with osteoarthritis (OA). SF-36 was compared to baseline and the US normative values after 26 weeks, and after an additional injection followed by another 26 weeks. The study found significant improvements in quality of life compared to baseline in patients treated with BioHA which trended towards normative values for the US population after a single and a repeat injection.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
